Premium
Glassy Cell Carcinoma of the Uterine Cervix: Combination Chemotherapy with Paclitaxel and Carboplatin in Recurrent Tumor
Author(s) -
Matsuura Yusuke,
Murakami Nobuko,
Nagashio Eiji,
Toki Naoyuki,
Kashimura Masamichi
Publication year - 2001
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/j.1447-0756.2001.tb01236.x
Subject(s) - carboplatin , medicine , paclitaxel , chemotherapy , radiation therapy , oncology , cervix , carcinoma , cisplatin , radiology , urology , cancer
Combination chemotherapy with paclitaxel and carboplatin every 4 weeks for 3 cycles was administered for recurrent glassy cell carcinoma of the uterine cervix in a 67‐year‐old Japanese female. The response rate was 56% under computed tomography (partial response). However, the effect was transient even with follow‐up radiotherapy, and further cases need to be accumulated to determine a successful treatment modality.